RAF1 and esophageal squamous cell carcinoma: To further confirm that the oncogenic effect of PAK1 was through activation of the Raf1/MEK/ERK cascade, U0126, a selective MEK inhibitor, was applied to check whether it abolishes the effect of PAK1 in ESCC cells.